InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (11 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
11
T+90 hit rate
40%
T+90 mean return
-6.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Epperly Melissa B, Chief Financial Officer. Director active across 2 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 30 reports have been logged. Breakdown: 2 buys · 11 sells. Total volume traded: €1m. History available since 3 May 2021. The latest transaction was disclosed on 17 April 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations30 total
1,847 shares0Common SharesSEC:0001140361-25-014802:0
1,672 shares0Common SharesSEC:0001140361-25-002102:0
1,613 shares0Common SharesSEC:0001140361-24-044060:0
4,245 shares@ US$12.12100.0% of flowCommon SharesSEC:0001140361-24-041233:0
16,406 shares0Common SharesSEC:0001140361-24-040987:0
1,702 shares0Common SharesSEC:0001140361-24-034279:0
1,146 shares0Common SharesSEC:0001140361-24-022617:0
2,573 shares@ US$11.440.9% of flowCommon StockSEC:0001725160-24-000043:0
75,000 shares0Common StockSEC:0001725160-24-000028:0
1,207 shares0Common SharesSEC:0001140361-24-003552:0
1,226 shares0Common SharesSEC:0001140361-23-048775:0
4,594 shares@ US$19.42652.8% of flowCommon StockSEC:0001725160-23-000179:0
17,825 shares0Common SharesSEC:0001140361-23-044045:0
1,280 shares0Common SharesSEC:0001140361-23-033547:0
2,624 shares@ US$20.42441.7% of flowCommon StockSEC:0001725160-23-000035:0
101,957 shares0Common StockSEC:0001725160-23-000017:0
50,000 shares0Common StockSEC:0001725160-22-000180:0
8,094 shares@ US$48.74750.12% mcap12.7% of flowCommon StockSEC:0001725160-22-000069:0
1,211 shares@ US$48.81030.018% mcap1.8% of flowCommon StockSEC:0001725160-22-000047:0
16,405 shares0Common StockSEC:0001725160-22-000033:0
17,080 shares@ US$67.130.34% mcap34.9% of flowCommon StockSEC:0001725160-21-000199:0
17,080 shares@ US$67.130.34% mcap82.1% of flowCommon StockSEC:0001725160-21-000199
1,326 shares@ US$51.9970.020% mcap2.1% of flowCommon StockSEC:0001725160-21-000185:0
Ideal exit: 15 May 2022 (T+270)
1,326 shares@ US$51.9972.0% of flowCommon StockSEC:0001725160-21-000185
Ideal exit: 15 May 2022 (T+270)
700 shares@ US$50.10431.0% of flowCommon StockSEC:0001725160-21-000163
25 of 30 declarations
About Epperly Melissa B,
Melissa B. Epperly is the Chief Financial Officer at Zentalis Pharmaceuticals, Inc. In this role, she oversees financial operations and ensures compliance with regulations. With expertise in finance, she plays a crucial role in the financial management of the company.
